Connect with us

Technology

Organizations Must Navigate DEI Resistance and Misconceptions to Enable an Inclusive Future for All, Says HR Research & Advisory Firm McLean & Company

Published

on

According to a new resource from global HR research and advisory firm McLean & Company, HR and DEI leaders face shifting challenges, misconceptions, and resistance in the DEI space as they seek to guide their organizations into an inclusive future of work. Leaders must uncover the root causes of DEI resistance to effectively address these challenges and enable building a diverse, inclusive, and equitable organization for all.

TORONTO, July 31, 2024 /CNW/ – As the diversity, equity, and inclusion (DEI) landscape continues to evolve, HR is navigating how to address misconceptions and sources of resistance to organizational DEI. In response, McLean & Company, the trusted research and advisory partner of HR leaders around the world, has released a new resource to support HR and DEI leaders advocating for greater inclusion and equity in their talent practices and workplaces. The guide, Navigate a Path Forward in the DEI Landscape, explores the evolution and current importance of DEI as well as the common misconceptions fueling resistance. McLean & Company’s new resource also offers insights on how best to integrate strategies to address six common types of DEI resistance alongside integrating the importance of DEI into organizational culture.

In the resource, the firm explains that the benefits of organizational DEI, including improved financial performance and organizational outcomes, are undeniable and lead most organizations to use the business case to advocate for continued investment in DEI. However, this approach can overlook the fairness and empathy case, which anchors the importance of DEI in achieving improved equitable outcomes, building a sense of belonging, and working to improve society. The firm further stresses that deprioritizing DEI because of resistance is a mistake and that failing to address equity and inclusion challenges hinders employee and organizational outcomes.

“Regardless of the specifics of their approach, DEI leaders face no shortage of challenges, misconceptions, and resistance on the path to building a diverse, inclusive, and equitable organization,” says Elysca Fernandes, director of HR Research & Advisory Services at McLean & Company. “Amid adversity, DEI leaders can sustain progress by focusing on the people most impacted by DEI challenges to achieve an inclusive future for all.”

To support HR and DEI leaders in their efforts to understand DEI obstacles and navigate the course to create and maintain an inclusive workplace for all, McLean & Company has organized the new guide into three sections:

1.  What is DEI today? The first section offers HR and DEI leaders a high-level review of terms. They’ll also gain an understanding of the benefits of organizational DEI and its evolution to the present day.

2.  Where are we now? The second section explains six common types of resistance and how they may appear in the workplace:

          i.     Perceiving DEI progress through a zero-sum mindset. A zero-sum mindset refers to the belief that progress in DEI comes at the expense of those who have historically benefited from existing systems or structures, assuming opportunities are finite and limited rather than expansive or created.

         ii.     Failing to acknowledge the impact of systemic inequities on workplace outcomes, commonly known as the meritocracy myth.

        iii.     Misinterpreting inclusion in one domain to justify exclusion in another.

        iv.     Empathy deficits leading to the belief that things are “good enough.”

        v.     Lack of recognition of the indirect and long-term value of investing in DEI.

        vi.     Focusing on perceptions and losing sight of the impact of DEI-related change.

3.  Where do we go from here? The third and final section encourages HR and DEI leaders to approach DEI as long-term cultural change   through aligning the focus of DEI with the organization’s stated values of wellbeing and safety. To achieve this, the resource points to the  importance of segmenting employee experience data to uncover exclusion and hidden disparities, adopting inclusive design to create a more inclusive workplace, and encouraging continuous learning and unlearning along the DEI journey.

McLean & Company reminds leaders that DEI is highly contextual and requires adapting the approach to differing contexts and audiences. Shifting mindsets is not easy, especially when views are based on deeply ingrained values and learned behaviors. Culture change does not happen overnight, so future-focused leaders must embrace embedding inclusion into organizational culture as a long-term journey.

To access the full thought leadership resource, please visit Navigate a Path Forward in the DEI Landscape.

To learn more about the resources and tools available to support navigating the current DEI landscape and the best way forward for organizations’ unique contexts, please contact McLean & Company.

To attend upcoming free webinars on a variety of topics or explore the publicly available archive of recorded sessions, please visit McLean & Company’s webinars page.

McLean Signature 2024 Conference

To register for Signature, McLean & Company’s premier industry conference for future-focused HR leaders, please visit the official Signature event page. This year Signature will take place from October 27 to 29 at Red Rock Casino Resort & Spa in Las Vegas, Nevada.

Media interested in connecting with McLean & Company analysts for exclusive, research-backed insights and commentary on generative AI in HRHR trends in 2024the future of work, and more can contact Senior Communications Manager Kelsey King at kking@mcleanco.com

About McLean & Company

McLean & Company pairs evidence-based research and immediately applicable tools with deep HR expertise to position organizations to meet today’s needs and prepare for the future. The global HR research and advisory firm’s member organizations enjoy comprehensive resources, full-service diagnostics, workshops, action plans, and advisory services for all levels of HR professionals, from executive leadership to HR leaders to HR team members, that help shape workplaces where everyone thrives.

McLean & Company is a division of Info-Tech Research Group.

Media professionals can register for unrestricted access to research across IT, HR, and software and hundreds of industry analysts through the firm’s Media Insiders program. To gain access, contact kking@mcleanco.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/organizations-must-navigate-dei-resistance-and-misconceptions-to-enable-an-inclusive-future-for-all-says-hr-research–advisory-firm-mclean–company-302211249.html

SOURCE McLean & Company

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Baidu to Report First Quarter 2026 Financial Results on May 18, 2026

Published

on

By

BEIJING, April 23, 2026 /PRNewswire/ — Baidu, Inc. (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) (“Baidu” or the “Company”), a leading AI company with strong Internet foundation, today announced that it will report its financial results for the First Quarter 2026 ended March 31, 2026, before the U.S. market opens on May 18, 2026. Baidu’s management will hold an earnings conference call at 8:00 AM on May 18, 2026, U.S. Eastern Time (8:00 PM on May 18, 2026, Beijing Time).

Please register in advance of the conference call using the link provided below. It will automatically direct you to the registration page of “Baidu Inc. Q1 2026 Earnings Conference Call”. Please follow the steps to enter your registration details, then click “Register”. Upon registering, you will then be provided with the dial-in number, the passcode, and your unique access PIN. This information will also be emailed to you as a calendar invite.

For pre-registration, please click:
https://s1.c-conf.com/diamondpass/10054331-iu876y.html

In the 10 minutes prior to the call start time, you may use the conference access information (including dial-in number(s), the passcode and unique access PIN) provided in the calendar invite that you have received following your pre-registration.

Additionally, a live and archived webcast of this conference call will be available at https://ir.baidu.com.

A replay of the conference call may be accessed by phone at the following number until May 25, 2026:
US: 1 855 883 1031
Reply PIN: 10054331

About Baidu

Founded in 2000, Baidu’s mission is to make the complicated world simpler through technology. Baidu is a leading AI company with strong Internet foundation, trading on Nasdaq under “BIDU” and the HKEX under “9888.” One Baidu ADS represents eight Class A ordinary shares.

View original content:https://www.prnewswire.com/news-releases/baidu-to-report-first-quarter-2026-financial-results-on-may-18-2026-302751204.html

SOURCE Baidu, Inc.

Continue Reading

Technology

Phase 1 of 139th Canton Fair Introduces New Dedicated Product Zones as Emerging Technologies Take Center Stage

Published

on

By

GUANGZHOU, China, April 23, 2026 /PRNewswire/ — The 139th China Import and Export Fair (Canton Fair) has further optimized its exhibition landscape with nine new dedicated product zones, reflecting ongoing structural shifts in global trade and the continued upgrading of China’s export portfolio.

Among the most closely watched additions in Phase 1 are the consumer and agricultural drone zones, both making their debut at the Canton Fair and offering a focused showcase of applications in the low‑altitude economy. The consumer drone zone showcases progress in flight control, AI‑based obstacle avoidance and energy efficiency across imaging, tourism, emergency response and patrol. The agricultural drone zone highlights precision farming, with spraying, seeding and field‑management demonstrations showing terrain‑following, intelligent route planning, and precise payload control.

On day one, a Shandong‑based drone manufacturer welcomed buyers from 30+ countries, with over 50 strong leads. One buyer, after seeing load and wind‑resistance demonstrations, immediately confirmed three sample units and even proposed becoming a regional distributor.

Display technology is another focal point of Phase 1, highlighting advances in color accuracy, energy efficiency, and overall visual performance. Developments in fine‑grained control, expanded color gamut, and reduced power consumption point to a clear trend toward immersive viewing experiences combined with sustainability gains.

The smart wearables zone underscores how intelligent devices are becoming key interfaces for human‑machine interaction. From real‑time language translation and adaptive noise cancellation to long‑term health monitoring and AI‑enabled eyewear, wearables are evolving from standalone products into integrated systems that support communication, well‑being, and productivity across daily and professional settings.

The service robots zone further illustrates how artificial intelligence is moving from conceptual exploration to large‑scale deployment. Advanced robots showcased across industrial, commercial, medical, and public‑service scenarios demonstrate growing autonomy, multi‑sensory perception, and closer human-robot collaboration.

By bringing emerging technologies into clearer focus through dedicated zones, the 139th Canton Fair is reinforcing its function as a platform where trade trends take shape, innovation meets application, and global buyers gain early insights into cutting-edge technologies.

For pre-registration, please click: https://buyer.cantonfair.org.cn/register/buyer/email?source_type=16

Photo – https://mma.prnewswire.com/media/2963958/1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/phase-1-of-139th-canton-fair-introduces-new-dedicated-product-zones-as-emerging-technologies-take-center-stage-302751520.html

Continue Reading

Technology

OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&D

Published

on

By

By combining structured clinical intelligence with AI-driven portfolio planning, the partnership gives pharmaceutical teams a faster, clearer way to make high-stakes R&D decisions

SPRING LAKE HEIGHTS, N.J., April 23, 2026 /PRNewswire/ — OZMOSI, a leading provider of structured pharmaceutical development intelligence, today announced a strategic partnership with Planview, the leading AI-powered end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD).

By integrating OZMOSI’s machine-readable clinical datasets directly into Planview’s AI-driven portfolio planning platform, external scientific data is now connected to internal R&D planning in one system,  helping pharmaceutical organizations better predict market shifts, prioritize R&D investments, and make faster, more confident decisions.

This integration brings external clinical reality into internal R&D decision-making, so teams can plan based on what’s actually happening, not just on what they hope will happen.

The two organizations combine deep expertise in complementary areas, united by a shared focus on improving the quality and usability of data for strategic decision-making. OZMOSI provides structured, machine-readable intelligence across clinical trials, drug development programs, regulatory activity, and scientific literature, built on a consistent taxonomy that standardizes how data is connected and understood. Planview’s platform enables organizations to model complex investment scenarios, align initiatives with corporate strategy, and optimize resource allocation.

Together, these capabilities give teams a clearer, more complete view of the R&D landscape, grounded in clean, standardized data and strengthened by AI-driven analysis.

“AI is only as powerful as the data that fuels it,” said Beau Bush, President and Founder of OZMOSI. “Pharmaceutical organizations have no shortage of data, but too often it’s fragmented, inconsistent, and difficult to operationalize. By bringing OZMOSI’s structured data foundation together with Planview’s AI-driven planning capabilities, we’re enabling teams to move beyond disconnected analysis and toward truly integrated, forward-looking decision-making.”

“Strategic planning in pharmaceutical R&D is becoming increasingly dependent on advanced analytics and AI,” said  Louise Allen, Chief Product Officer at Planview. “Integrating OZMOSI’s clinical intelligence into Planview’s platform enables pharmaceutical leaders to make better decisions by combining trusted external data with AI-driven planning

OZMOSI’s dataset spans more than 800,000 clinical trials, over 35,000 drugs, and 4,000 diseases and conditions. It brings together insights from clinical trial registries, regulatory filings, scientific literature, company disclosures, and industry announcements into a unified, structured dataset.

When integrated into Planview’s platform, this intelligence enables pharmaceutical and biotech organizations to evaluate competitive landscapes, identify emerging clinical trends, and simulate portfolio outcomes with unprecedented precision.

Together, OZMOSI and Planview are redefining how pharmaceutical organizations approach R&D strategy, ensuring that investment decisions are guided by accurate, standardized, and AI-ready data. By combining internal portfolio visibility with a continuously updated external view of the market, the partnership helps leaders not only understand what they have, but what to do next.

About OZMOSI

Founded in 2013, OZMOSI specializes in transforming complex pharmaceutical R&D intelligence into structured, machine-readable data. The company provides the foundation needed for accurate competitive analysis, product forecasting, and portfolio strategy. Through its proprietary taxonomy and semantic layer, OZMOSI connects fragmented data across the pharmaceutical ecosystem, enabling faster, more confident decision-making for global pharma, biotech, and investment teams.

Based in Spring Lake Heights, New Jersey, OZMOSI is focused on making pharmaceutical intelligence clear, usable, and ready for the future of AI-driven strategy. Learn more at www.ozmosi.com.

About Planview

Planview is the leading end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD), powered by advanced AI capabilities that give business and technology leaders the strategic foresight to prioritize investments and initiatives, make plans real within constraints, and pivot with certainty when things change. Our AI-driven connected platform of solutions underpins the business and digital transformations of more than 3,000 customers and 3.1 million users globally. Headquartered in Austin, Texas, Planview has over 1,500 employees worldwide. Learn more at www.planview.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ozmosi-announces-strategic-partnership-with-planview-to-advance-ai-driven-planning-in-pharmaceutical-rd-302750944.html

SOURCE Ozmosi Company

Continue Reading

Trending